Indavel Pharma
At risk30/100SmallPharmaceutical
About this account
Small generic pharma company, ~80 employees, focused on ANDA filings for US market entry. First-time FDA submitter.
Relationship health
30/100 · At riskHow this account's health has moved over the last 5 weeks.
100 pts0 pts
4w ago2w agothis week
How touches have landed
Every logged touch with Indavel Pharma, by outcome.
No activity yet
The first call, email, meeting, or note will build this account's outcome mix.
Company profile
Not analyzed yet — analyze to qualify its type, ownership and revenue from the web, and the offerings that fit show automatically.
Agent briefing
Indavel Pharma needs attention — at risk, with $0 in open pipeline at stake. It's single-threaded, so widening the relationship would de-risk the deal. Recommended next move: Stabilize Indavel Pharma.
HealthAt risk (30/100).
Pipeline0 open deals worth $0.
ThreadingSingle-threaded — widen the relationship to de-risk.
MomentumNo activity logged yet — open the relationship.
Recommended: Stabilize Indavel Pharma
Value PropositionsAI generated
No matched services yet — generate a session.
Angles to researchAI generated
Agent-suggested things worth checking before you reach out — verify before you rely on them.
Regulatory
Check for recent Pharmaceutical guidance that could tighten their submission timelines — a timely reason to reach out.
Hiring
See whether Indavel is hiring in regulatory affairs — a growing team often means more submission workload they may need help with.